The rate of drug particle detachment from carrier crystals in an air classifier-based inhaler

Pharmaceutical Research

Volumn 21, Issue 12, 2004, Pages 2158-2166

  De Boer, Anne H ^a   Hagedoorn, Paul ^a   Gjaltema, Doetie ^a   Lambregts, Dorette ^b   Irngartinger, Meike ^c   Frijlink, Henderik W ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b DMV International   (Netherlands)

^c Sofotec GmbH   (Germany)

Author keywords

Adhesive mixtures; Air classifier; Carrier residue; Dry powder inhaler with residence time; Particle detachment rate

Indexed keywords

BUDESONIDE; DRUG CARRIER;

AEROSOL; ARTICLE; CIRCULATION; CONCENTRATION RESPONSE; CRYSTAL STRUCTURE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; EXERCISE; FLOW RATE; FORCE; LASER DIFFRACTION; POWDER INHALER; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE;

CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; DRUG CARRIERS; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE;

EID: 14544306695     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11095-004-7668-4     Document Type: Article

References (30)

1. F. Podczeck. Assessment of the mode of adherence and the deformation characteristics of micronized particles adhering to various surfaces. Int. J. Pharm. 145:65-76 (1996).
2. F. Podczeck. Adhesion forces in interactive powder mixtures of a micronized drug and carrier particles of various particle size distributions. J. Adhes. Sci. Technol. 12:1323-1339 (1998).
3. J. Visser. Van der Waals and other cohesive forces affecting powder fluidization. Powd. Technol. 58:1-10 (1989).
4. D. Zang and W. J. Whiten. The calculation of contact forces between particles using spring and damping models. Powd. Technol. 88:59-64 (1996).
5. W.-I. Li, M. Perzl, J. Heyder, R. Langer, J. D. Brain, K.-H. Englmeier, R. W. Niven, and D. A. Edwards. Aerodynamics and aerosol particle deaggregation phenomena in model oral-pharyngeal cavities. J. Aerosol Sci. 8:1269-1286 (1996).
6. H. Steckel and B. W. Müller. In vitro evaluation of dry powder inhalers II: influence of carrier particle size and concentration on in vitro deposition. Int. J. Pharm. 154:31-37 (1997).
7. B. H. J. Dickhoff, A. H. de Boer, D. Lambregts, and H. W. Frijlink. The effect of carrier surface and bulk properties on drug particle detachment from crystalline lactose carrier particles during inhalation, as function of carrier payload and mixing time. Eur. J. Pharm. Biopharm. 56:291-302 (2003).
8. X. M. Zeng, K. H. Pandhal. and G. P. Martin. The influence of lactose carrier on the content homogeneity and dispersibility of beclomethasone dipropionate from dry powder aerosols. Int. J. Pharm. 197:41-52 (2000).
9. R. Price, P. M. Young. S. Edge, and J. N. Staniforth. The influence of relative humidity on particle interactions in carrier-based dry powder inhaler formulations. Int. J. Pharm. 246:47-59 (2002).
10. L. Maggi, R. Bruni, and U. Conte. Influence of the moisture on the performance of a new dry powder inhaler. Int. J. Pharm. 177: 83-91 (1999).
11. P. A. Carter, G. Rowley, E. J. Fletcher, and E. A. Hill. An experimental investigation of triboelectrification in cohesive and non-cohesive pharmaceutical powders. Drug Dev. Ind. Pharm. 18:1505-1526 (1992).
12. K. Schönert, K. Eichas, and F. Niermöller. Charge distribution and state of agglomeration after tribocharging fine particulate materials. Powd. Technol. 86:41-47 (1996).
13. F. Podczeck. The relationship between physical properties of lactose monohydrate and the aerodynamic behaviour of adhered drug particles. Int. J. Pharm. 160:119-130 (1998).
14. P. Harjunen, V-P Lehto, K. Martimo, E. Suihko, T. Lankinen, P. Paronen, and K. Järvinen. Lactose modifications enhance its drug performance in the novel multiple dose Taifun® DPI. Eur. J. Pharm. Sci. 16:313-321 (2002).
15. H. Larhrib, X. M. Zeng. G. P. Martin. Ch. Marriott, and J. Pritchard. The use of different grades of lactose as a carrier for aerosolised salbutamol sulphate. Int. J. Pharm. 191:1-14 (1999).
16. M. D. Louey, S. Razia, and P. J. Stewart. Influence of physicochemical carrier properties on the in vitro aerosol deposition from interactive mixtures. Int. J. Pharm. 252:87-98 (2003).
17. Y. Kawashima, T. Serigano, T. Hino, H. Yamamoto, and H. Takeuchi. Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrate. Int. J. Pharm. 172:179-188 (1988).
18. X. M. Zeng, G. P. Martin, Ch. Marriott, and J. Pritchard. The influence of carrier morphology on drug delivery by dry powder inhalers. Int. J. Pharm. 200:93-106 (2000).
19. X. M. Zeng, G. P. Martin, Ch. Marriott, and J. Pritchard. Lactose as a carrier in dry powder formulations: the influence of surface characteristics on drug delivery. J. Pharm. Sci. 90:1424-1434 (2001).
20. K. Iida, Y. Hayakawa, H. Okamoto, K. Danjo, and H. Leuenberger. Preparation of dry powder inhalation by surface treatment of lactose carrier particles. Chem. Pharm. Bull. (Tokyo) 51:1-5 (2003).
21. X. M. Zeng, G. P. Martin, Ch. Marriott, and J. Pritchard. The use of lactose recrystallised from carbopol gels as a carrier for aerosolised salbutamol sulphate. Eur. J. Pharm. Biopharm. 51:55-62 (2001).
22. P. M. Young. D. Cocconi, P. Colombo. R. Bettini, R. Price, D. F. Steele, and M. J. Tobyn. Characterization of a surface modified dry powder inhalation carrier prepared by 'particle smoothing'. J. Pharm. Pharmacol. 54:1339-1344 (2002).
23. K. K. Lam and J. M. Newton. Influence of particle size on the adhesion behaviour of powders, after application of an initial press-on force. Powd. Technol. 73:117-125 (1992).
24. F. Podczeck. Assessment of the mode of adherence and the deformation characteristics of micronized particles adhering to various surfaces. Int. J. Pharm. 145:65-76 (1996).
25. N. Y. K. Chew, H.-K. Chan, D. F. Bagster, and J. Mukhraiya. Characterization of pharmaceutical powder inhalers: estimation of energy input for powder dispersion and effect of capsule device configuration. Aerosol Sci. 33:999-1008 (2002).
26. H. Steckel and B. W. Müller. In vitro evaluation of dry powder inhalers I: drug deposition of commonly used devices. Int. J. Pharm. 154:19-29 (1997).
27. A. H. de Boer. P. Hagedoorn, D. Gjaltema, J. Goede, and H. W. Frijlink. Air classifier technology (ACT) in dry powder inhalation part 1. Introduction of a novel force distribution concept (FDC) explaining the performance of a basic air classifier on adhesive mixtures. Int. J. Pharm. 260:187-200 (2003).
28. A. H. de Boer, D. Gjaltema, P. Hagedoorn, M. Schaller, W. Witt, and H. W. Frijlink. Design and application of a new modular adapter for laser diffraction characterization of inhalation aerosols. Int. J. Pharm. 249:233-245 (2003).
29. A. H. de Boer, P. Hagedoorn, D. Gjaltema, J. Goede, K. D. Kussendrager, and H. W. Frijlink. Air classifier technology (ACT) in dry powder inhalation part 2: The effect of lactose carrier surface properties on the drug-to-carrier interaction in adhesive mixtures for inhalation. Int. J. Pharm. 260:201-216 (2003).
30. P. O. J. Kulvanich and P. J. Stewart. The effect of particle size and concentration on the adhesive characteristics of a model drug-carrier interactive system. J. Pharm. Pharmacol. 39:673-678 (1987).